PECK MADIGAN JONES (ON BEHALF OF BIO)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2015

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
TIBER CREEK HEALTH STRATEGIES, INC.	—	21

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	15
HOUSE OF REPRESENTATIVES	9
White House Office	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	16
Medicare/Medicaid	Medicare/Medicaid	15
Pharmacy	Pharmacy	13
Copyright/Patent/Trademark	Copyright/Patent/Trademark	4
Budget/Appropriations	Budget/Appropriations	4
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	4
Small Business	Small Business	2

Bills Explicitly Cited (1)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · third_quarter · Firm: TIBER CREEK HEALTH STRATEGIES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation impacting patent settlements. Proposed Medicare and Medicaid cuts, including changes to Part D and Part B. "Track and Trace" legislation. Drug imporation. H.R. 3204, Drug Quality and Security Act.

Client expense: — · Firm income: —

Matched citations: H.R. 3204

Source: Senate LDA

PECK MADIGAN JONES (ON BEHALF OF BIO) — Lobbying Disclosure | Poliscope